Neogen Crecimiento futuro

Future controles de criterios 3/6

Neogen is forecast to grow earnings and revenue by 123.4% and 2.6% per annum respectively while EPS is expected to grow by 122.8% per annum.

Información clave

123.4%

Tasa de crecimiento de los beneficios

122.8%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Medical Equipment	16.1%
Tasa de crecimiento de los ingresos	2.6%
Rentabilidad financiera futura	n/a
Cobertura de analistas	Low
Última actualización	15 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12

Recent updates

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Apr 15

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Apr 12

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Jan 12

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Jan 09

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Dec 06

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Jul 12

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Jun 20

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Mar 25

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Oct 10

Neogen GAAP EPS of $0.05, revenue of $132.35M

Sep 27

Neogen drops 9% as merger with 3M’s food safety business closes

Sep 01

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Aug 21

Neogen: Cut In Half, Still Some Questions

Aug 12

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

Aug 04

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Aug 01

Neogen FQ4 2022 Earnings Preview

Jul 25

Zoetis, IDEXX named as buys in animal health space by Piper Sandler

Jul 13

Neogen announces pricing of $350M senior notes offering

Jul 07

Neogen: Safety Food Giant In The Making

Dec 15

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Dec 12

Neogen (NASDAQ:NEOG) Will Want To Turn Around Its Return Trends

Sep 12

Robust Valuation Leaves Neogen Little Room For Error After Mixed Results

Jul 27

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:NEOG - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
5/31/2026	978	22	N/A	N/A	2
5/31/2025	938	3	N/A	N/A	2
5/31/2024	912	-8	N/A	N/A	2
2/29/2024	929	2	-13	99	N/A
11/30/2023	919	12	17	113	N/A
8/31/2023	919	-27	-5	78	N/A
5/31/2023	822	-23	-25	41	N/A
2/28/2023	721	-13	-82	-30	N/A
11/30/2022	631	-16	-50	-6	N/A
8/31/2022	531	36	-5	31	N/A
5/31/2022	527	48	44	68	N/A
2/28/2022	514	49	50	70	N/A
11/30/2021	503	57	54	75	N/A
8/31/2021	487	62	55	79	N/A
5/31/2021	468	61	54	81	N/A
2/28/2021	450	61	58	85	N/A
11/30/2020	433	60	71	93	N/A
8/31/2020	426	61	65	87	N/A
5/31/2020	418	59	62	86	N/A
2/29/2020	419	59	62	81	N/A
11/30/2019	417	60	51	72	N/A
8/31/2019	416	60	52	71	N/A
5/31/2019	414	60	49	64	N/A
2/28/2019	413	62	49	66	N/A
11/30/2018	410	65	57	74	N/A
8/31/2018	403	66	48	67	N/A
5/31/2018	398	63	48	69	N/A
2/28/2018	389	58	44	62	N/A
11/30/2017	382	52	N/A	58	N/A
8/31/2017	372	46	N/A	59	N/A
5/31/2017	358	44	N/A	60	N/A
2/28/2017	353	41	N/A	53	N/A
11/30/2016	341	39	N/A	44	N/A
8/31/2016	330	37	N/A	49	N/A
5/31/2016	321	37	N/A	35	N/A
2/29/2016	310	36	N/A	38	N/A
11/30/2015	301	35	N/A	41	N/A
8/31/2015	290	34	N/A	40	N/A
5/31/2015	283	34	N/A	44	N/A
2/28/2015	272	32	N/A	38	N/A
11/30/2014	265	31	N/A	34	N/A
8/31/2014	256	29	N/A	27	N/A
5/31/2014	247	28	N/A	22	N/A
2/28/2014	236	28	N/A	24	N/A
11/30/2013	225	28	N/A	26	N/A
8/31/2013	216	28	N/A	28	N/A
5/31/2013	208	27	N/A	27	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: NEOG's forecast earnings growth (123.4% per year) is above the savings rate (2.3%).

Beneficios vs. Mercado: Se prevé que los beneficios (123.4% al año) de NEOG crezcan más rápidamente que el mercado US (14.7% al año).

Beneficios de alto crecimiento: NEOG's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: Se prevé que los ingresos (2.6% al año) de NEOG crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 2.6% al año) de NEOG crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de NEOG se prevé que sea elevada dentro de 3 años.

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Neogen Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target decreased by 11% to US$17.00

Consensus EPS estimates have been downgraded.

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen Corporation Updates Earnings Guidance for the Full Year 2024

Consensus EPS estimates fall by 25%

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Recent updates

Neogen® Launches New Molecular Method for Detection of Two Salmonella Serotypes

Price target decreased by 11% to US$17.00

Consensus EPS estimates have been downgraded.

Battered By M&A Integration Issues, Neogen Has To Rebuild Investor Trust

Neogen Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next

Neogen®? Farm Fluid Max Disinfectant Launches Across Great Britain Livestock & Poultry Markets

President recently bought US$284k worth of stock

Third quarter 2024 earnings: EPS misses analyst expectations

Neogen Corporation Updates Earnings Guidance for the Full Year 2024

Neogen Corporation Announces Board Changes

Neogen (NASDAQ:NEOG) Takes On Some Risk With Its Use Of Debt

Neogen: All About Execution From Here On

Neogen Corporation to Report Q3, 2024 Results on Apr 09, 2024

Consensus EPS estimates fall by 25%

Neogen® Releases Surekill® Gel Bait Pro Applicator

Statutory Profit Doesn't Reflect How Good Neogen's (NASDAQ:NEOG) Earnings Are

Neogen Corporation Just Missed Earnings With A Surprise Loss - Here Are Analysts Latest Forecasts

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Neogen Corporation (NASDAQ:NEOG) Investors Are Less Pessimistic Than Expected

Neogen Corporation Provides Earnings Guidance for the Fiscal Year 2024

Neogen Corporation to Report Q2, 2024 Results on Jan 09, 2024

Here's Why Neogen (NASDAQ:NEOG) Can Manage Its Debt Responsibly

Neogen®? Launches Highly Sensitive Quantitative Elisa Assay for the Detection of Walnut Allergens

Price target decreased by 14% to US$22.25

Neogen Corporation Provides Revenue Guidance for the Fiscal Year 2024

Neogen Corporation to Report Q1, 2024 Results on Oct 10, 2023

Neogen Corporation, Annual General Meeting, Oct 25, 2023

Neogen® Launches Igenity® Enhanced Dairy

Neogen Corporation Unveils over 100 New Genetic Tests

Neogen Corporation announced delayed annual 10-K filing

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Neogen Corporation to Report Q4, 2023 Results on Jul 27, 2023

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Is There An Opportunity With Neogen Corporation's (NASDAQ:NEOG) 46% Undervaluation?

Neogen Corporation Launches DNA Test for Beef-on-Dairy Cattlec

Neogen Corporation Launches New Assays for Histamine Detection

Neogen Corporation Launches New Assays for Natural Toxin Detection

Third quarter 2023 earnings: EPS exceeds analyst expectations

Neogen (NASDAQ:NEOG) Has A Somewhat Strained Balance Sheet

Second quarter 2023 earnings: EPS misses analyst expectations

Neogen Corporation to Report Q2, 2023 Results on Jan 05, 2023

Price target decreased to US$14.00

Neogen Corporation Launches Synergize Disinfectant in Europe, the Middle East, Africa

Neogen Corporation Launches Ready-To-Use Chemiluminescent Substrate

Investor sentiment improved over the past week

Association of Official Analytical Chemists Approves Neogen Corporation's Megazyme Rapid Integrated Total Dietary Fiber Assay as the Standard Method

VP & CFO recently bought US$58k worth of stock

Investor sentiment deteriorated over the past week

Neogen Corporation Adds Companion™ Ready-To-Use Disinfectant to Biosecurity Portfolio

Neogen introduces ready-to-use disinfectant Companion RTU for veterinary use

Neogen Corporation Launches New Genomic Management Technology

President recently bought US$316k worth of stock

Neogen Corporation Announces Executive Changes

Neogen GAAP EPS of $0.05, revenue of $132.35M

Neogen Corporation Launches Quantitative Cashew ELISA Assay

Neogen Corporation Appoint Board of Directors

Investor sentiment deteriorated over the past week

Neogen Corporation (NasdaqGS:NEOG) completed the acquisition of Food Safety Business from 3M Company (NYSE:MMM).

Neogen drops 9% as merger with 3M’s food safety business closes

Neogen Corporation, Annual General Meeting, Oct 06, 2022

Price target decreased to US$23.00

Broker Revenue Forecasts For Neogen Corporation (NASDAQ:NEOG) Are Surging Higher

Consensus forecasts updated

Neogen: Cut In Half, Still Some Questions

There May Be Reason For Hope In Neogen's (NASDAQ:NEOG) Disappointing Earnings

President recently bought US$404k worth of stock

Price target increased to US$26.00

Neogen: Thesis Unchanged After Q4 And Full-Year Earnings

Full year 2022 earnings: EPS misses analyst expectations